These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Triglycerides and atherosclerosis: update and therapeutic recommendations]. Hussein O; Traub YM Harefuah; 1994 May; 126(10):593-7. PubMed ID: 8034250 [No Abstract] [Full Text] [Related]
23. [Endogenic hypertriglyceridemia and arteriosclerosis in the light of experimental studies]. Naruszewicz M Przegl Lek; 1982 Sep; 39(8):555-60. PubMed ID: 6753043 [No Abstract] [Full Text] [Related]
24. [Lipid disorders in non-insulin dependent diabetes--principles of treatment]. Idzior-Waluś B Przegl Lek; 1996; 53(9):653-9. PubMed ID: 8992531 [TBL] [Abstract][Full Text] [Related]
25. Clinical inquiries. What is the best strategy for monitoring the lipid-lowering effects of medical therapy used for the primary prevention of coronary artery disease (CAD)? Sherrod JP; Krist A J Fam Pract; 2001 Nov; 50(11):928. PubMed ID: 11711006 [No Abstract] [Full Text] [Related]
27. Relationship of serum C3 complement with insulin resistance and coronary heart disease-cause, consequence or common antecedent? Yudkin JS Eur Heart J; 2000 Jul; 21(13):1036-9. PubMed ID: 10843818 [No Abstract] [Full Text] [Related]
28. [Nutrition--a factor in preventing arteriosclerosis, coronary disease and blood coagulation disorders. II. The effect of nutritional imbalance on atherogenesis and the blood coagulation system]. Bazaz'ian GG Nauchnye Doki Vyss Shkoly Biol Nauki; 1984; (10):14-27. PubMed ID: 6391564 [TBL] [Abstract][Full Text] [Related]
29. [Nutrition--a factor in preventing arteriosclerosis, coronary disease and disorders of the blood coagulation system. I. An imbalance in food fats and carbohydrates and atherogenesis]. Bazaz'ian GG Nauchnye Doki Vyss Shkoly Biol Nauki; 1984; (6):5-13. PubMed ID: 6380598 [TBL] [Abstract][Full Text] [Related]
30. The unscientific emergence of coronary heart disease epidemiology. Stehbens WE Am Clin Lab; 1998 Sep; 17(8):4-5. PubMed ID: 10186947 [No Abstract] [Full Text] [Related]
31. Dyslipidemia and coronary heart disease: management issues from Indian perspective. Gambhir DS; Gambhir JK; Sudha R Indian Heart J; 2000; 52(5):515-6, 617. PubMed ID: 11256772 [No Abstract] [Full Text] [Related]
32. [Arteriosclerosis and the adipose tissue: the cause-effect interrelations]. Kukharenko SS; Nevokshanov OV; Aleksandrov AA Kardiologiia; 1991 Jul; 31(7):69-71. PubMed ID: 1779524 [No Abstract] [Full Text] [Related]
33. Heparin and atherosclerosis. Engelberg H Monogr Atheroscler; 1978; (8):1-69. PubMed ID: 360049 [No Abstract] [Full Text] [Related]
34. [Discovery of a new physiopathological aspect of arteriosclerosis and elucidation of its molecular mechanism]. Matsuzawa Y Nihon Naika Gakkai Zasshi; 2002 Sep; 91 Suppl():18-29. PubMed ID: 12577914 [No Abstract] [Full Text] [Related]
35. [Serum triglycerides. Mechanism of regulation; physiopathological implications]. Baltă N Med Interna (Bucur); 1971 Aug; 23(8):907-17. PubMed ID: 5093849 [No Abstract] [Full Text] [Related]
37. [Hyperlipidemia, hemodynamics and transcapillary metabolism in arteriosclerosis and ischemic heart disease]. Dzizinskiĭ AA; Chmir VP Kardiologiia; 1980 Sep; 20(9):107-13. PubMed ID: 6999210 [No Abstract] [Full Text] [Related]
38. [Problems of the pathogenesis of arteriosclerosis]. Gerasimova EN Ter Arkh; 1975; 47(7):15-24. PubMed ID: 178063 [No Abstract] [Full Text] [Related]
39. Lipids and their role in coronary heart disease: what they do and how to manage them. Pradka LR Nurs Clin North Am; 2000 Dec; 35(4):981-91. PubMed ID: 11072283 [TBL] [Abstract][Full Text] [Related] [Previous] [New Search]